Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03846804 · ClinicalTrials.gov registry record · NA
Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03846804 is a NA study that has completed, run by Indiana University. The registered enrollment target is 38 participants.
The verdict
NCT03846804, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of a blood test: Karius® plasma-based next-generation sequencing test (Karius Test), to see if we can detect and measure the infection causing agent in children with musculoskeletal infections (MSKI).
Interventions
- DIAGNOSTIC_TEST Karius Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03846804
The ClinicalTrials.gov registry entry for NCT03846804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Karius Test is the first listed.
NCT03846804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03846804 about?
NCT03846804 is a clinical study titled "Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections". The purpose of this study is to evaluate the use of a blood test: Karius® plasma-based next-generation sequencing test (Karius Test), to see if we can detect and measure the infection causing agent in children with musculoskeletal infections (MSKI).
What is the current status of trial NCT03846804?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-09-01. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT03846804?
The interventions under investigation include: Karius Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03846804?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.